SVA Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$6.77M Buy
86,769
+2,193
+3% +$168K 0.59% 34
2020
Q3
$6.69M Sell
84,576
-88
-0.1% -$6.89K 0.66% 33
2020
Q2
$6.25M Buy
84,664
+1,759
+2% +$132K 0.67% 30
2020
Q1
$6.09M Buy
82,905
+2,740
+3% +$215K 0.7% 28
2019
Q4
$6.96M Sell
80,165
-272
-0.3% -$22.3K 0.64% 33
2019
Q3
$6.46M Buy
80,437
+732
+0.9% +$58.7K 0.63% 33
2019
Q2
$6.38M Sell
79,705
-3,618
-4% -$277K 0.63% 33
2019
Q1
$6.61M Sell
83,323
-1,848
-2% -$138K 0.64% 37
2018
Q4
$6.21M Sell
85,171
-1,926
-2% -$136K 0.7% 37
2018
Q3
$5.9M Buy
87,097
+1,073
+1% +$68.4K 0.6% 48
2018
Q2
$4.98M Sell
86,024
-1,531
-2% -$86.4K 0.54% 53
2018
Q1
$5.35M Buy
87,555
+6,719
+8% +$363K 0.66% 45
2017
Q4
$4.34M Sell
80,836
-6,719
-8% -$372K 0.51% 52
2017
Q3
$5.35M Buy
87,555
+125
+0.1% +$7.58K 0.66% 45
2017
Q2
$5.35M Buy
87,430
+1,541
+2% +$93.8K 0.69% 44
2017
Q1
$5.21M Buy
85,889
+793
+0.9% +$48.1K 0.71% 42
2016
Q4
$4.78M Sell
85,096
-1,263
-1% -$73.9K 0.71% 44
2016
Q3
$5.14M Buy
86,359
+258
+0.3% +$15.1K 0.8% 40
2016
Q2
$4.73M Buy
86,101
+1,779
+2% +$94.7K 0.76% 40
2016
Q1
$4.26M Buy
84,322
+5,095
+6% +$250K 0.7% 46
2015
Q4
$3.99M Buy
79,227
+2,866
+4% +$144K 0.69% 46
2015
Q3
$3.6M Buy
76,361
+3,745
+5% +$199K 0.67% 53
2015
Q2
$3.94M Buy
72,616
+2,429
+3% +$136K 0.73% 49
2015
Q1
$3.85M Buy
70,187
+43,353
+162% +$2.45M 0.7% 52
2014
Q4
$1.45M Buy
26,834
+1,230
+5% +$68.5K 0.53% 43
2014
Q3
$1.45M Buy
25,604
+422
+2% +$23.7K 0.62% 39
2014
Q2
$1.39M Buy
25,182
+1,481
+6% +$80.8K 0.59% 42
2014
Q1
$1.28M Buy
23,701
+570
+2% +$29.5K 0.61% 43
2013
Q4
$1.1M Buy
+23,131
New +$1.06M 0.66% 41

Other funds holding MRK

SVA Wealth Management's MRK Position: Q4 2020 in Review

SVA Wealth Management increased its Merck (MRK) stake by 2.6% in Q4 2020, buying an estimated $168K and bringing the position to 86,769 shares worth $6.77M. The position accounts for 0.59% of the portfolio, ranked #34.

SVA Wealth Management first reported a position in MRK in Q4 2013 and has held it in 29 quarters since. The position peaked at $6.96M in Q4 2019. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • SVA Wealth Management held 86,769 shares of Merck worth $6.77M as of Q4 2020.
  • SVA Wealth Management bought 2,193 Merck shares in Q4 2020, an estimated $168K.
  • Merck made up 0.59% of SVA Wealth Management's portfolio in Q4 2020, its #34 holding.
  • SVA Wealth Management first reported a position in Merck in Q4 2013 and has held it in 29 quarters since.
  • SVA Wealth Management's Merck position peaked at $6.96M in Q4 2019.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.